HKHC Horizon Kinetics (HKHC) Insider Trading, Ownership & Congress Trades
Financial Services · Investment advice · CIK 0000088000
Cluster · 5 insidersC-suite buying · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about HKHC
Insiders, 180 days
+$127.5K net bought
5 buyers
Horizon Kinetics insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Horizon Kinetics Holding Corp insiders bought a net $127.5K of stock across 235 Form 4 purchases and sales, with 5 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Mar 20, 2026.
- +1.3% median (+11.9% mean) 90-day return after 3 previous buys.
- The trade is 32.2% of the 590 shares held after it.
- 4 other insiders bought within 30 days.
Insider activity: Director Nagelberg Allison bought about $5.0K of HKHC on Sep 18, 2026; 4 other insiders bought within 30 days.Context
- 7 earlier Form 4 trades (code P or S) here by this insider (7 buys), the last on Aug 28, 2026.
- +53.4% median (+28.7% mean) 90-day return after 3 previous buys.
- The trade is 10.0% of the 2,000 shares held after it.
- 4 other insiders bought within 30 days.
Insider activity: Director Brennan Alice C bought about $5.2K of HKHC on Sep 2, 2026; 4 other insiders bought within 30 days.Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 buys), the last on Aug 27, 2026.
- +53.4% median (+28.7% mean) 90-day return after 3 previous buys.
- The trade is 11.1% of the 1,800 shares held after it.
- 4 other insiders bought within 30 days.
Insider activity: Director Brennan Alice C bought about $5.2K of HKHC on Aug 28, 2026; 4 other insiders bought within 30 days.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 buys), the last on Aug 25, 2026.
- +53.4% median (+28.7% mean) 90-day return after 3 previous buys.
- The trade is 12.5% of the 1,600 shares held after it.
- 4 other insiders bought within 30 days.
Insider activity: Director Brennan Alice C bought about $5.2K of HKHC on Aug 27, 2026; 4 other insiders bought within 30 days.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 5.0% of the 10,000 shares held after it.
- 4 other insiders bought within 30 days.
Insider activity: Director Roller Daniel J bought about $13.2K of HKHC on Aug 26, 2026; 4 other insiders bought within 30 days.235 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$127.5K over 180 days
+$105.3K over 90 days
more than 83% of Financial Services
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+30.5% year over year
more than 69% of Financial Services
Margin
7.0% net margin
more than 53% of Financial Services
Buybacks
no share repurchases reported
Short interest
<0.1% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
the lowest in Financial Services
The situation: each line is one rule over one dataset
5 insiders independently bought a net $127.5K while the stock fell 25% over six months, with no planned sales queued.
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch HKHC
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-38.6%12M
Insider buy
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns HKHC: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in HKHC
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
HKHC planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$410.0K
$410.0K
$862.3K
+12%
n/a
2024
$406.0K
$386.4K
$970.0K
+70%
n/a
2022
$272.8K
$272.8K
$208.7K
n/a
n/a
2021
$166.2K
$166.2K
$268.2K
n/a
n/a
2020
$300.2K
-$35.0K
n/a
n/a
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
5 insiders reported buying shares.
The record shows a net $127.5K bought by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
HKHC financials
Revenue growth
+30.5%
XBRL, annual
Net margin
7.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Revenue, TTM HKHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | $16.6M |
| FY Dec 2021 | $33.1M |
| Jun 2026 | $19.0M |
| Mar 2026 | $18.3M |
| Dec 2025 | $17.0M |
| Sep 2025 | $17.9M |
| Jun 2025 | $19.8M |
| Mar 2025 | $19.8M |
| Dec 2024 | $14.7M |
| Sep 2024 | $15.4M |
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM HKHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | -53.4% |
| FY Dec 2021 | -33.5% |
| Jun 2026 | -96.5% |
| Mar 2026 | +396.5% |
| Dec 2025 | -84.9% |
| Sep 2025 | +40.4% |
| Jun 2025 | -53.1% |
| Mar 2025 | +115.4% |
| Dec 2024 | +513.8% |
| Sep 2024 | -248.4% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM HKHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | -$1.9M |
| FY Dec 2021 | -$339.0K |
| Jun 2026 | -$2.6M |
| Mar 2026 | -$7.4M |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | -$7.8M |
| Mar 2025 | -$14.5M |
| Dec 2024 | $23.0M |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
0.01x
LongTermDebt as filed 2022-12-31 (42 months older than the period end) (includes the current portion); equity 2026-06-30
Debt to equity HKHC
| FY Dec 2025 | 0.01x |
| FY Dec 2024 | 0.01x |
| FY Dec 2023 | 0.02x |
| FY Dec 2022 | 0.02x |
| FY Dec 2021 | 0.25x |
| Jun 2026 | 0.01x |
| Mar 2026 | 0.01x |
| Dec 2025 | 0.01x |
| Sep 2025 | 0.01x |
| Jun 2025 | 0.01x |
| Mar 2025 | 0.01x |
| Dec 2024 | 0.01x |
| Sep 2024 | 0.01x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-8.43x
TTM operating cash flow over LongTermDebt as filed 2022-12-31 (42 months older than the period end) (includes the current portion)
Cash flow to debt HKHC
| FY Dec 2025 | -12.29x |
| FY Dec 2024 | 3.38x |
| FY Dec 2023 | 7.27x |
| FY Dec 2022 | -0.53x |
| FY Dec 2021 | -0.11x |
| Jun 2026 | -8.43x |
| Mar 2026 | -10.09x |
| Dec 2025 | -12.29x |
| Sep 2025 | -4.92x |
| Jun 2025 | 1.39x |
| Mar 2025 | -6.15x |
| Dec 2024 | 3.38x |
| Sep 2024 | -2.70x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity HKHC
| FY Dec 2025 | +1.5% |
| FY Dec 2024 | +33.7% |
| FY Dec 2023 | -2.1% |
| FY Dec 2022 | -7.5% |
| FY Dec 2021 | -65.2% |
| Jun 2026 | +12.7% |
| Mar 2026 | +14.2% |
| Dec 2025 | +1.5% |
| Sep 2025 | +30.7% |
| Jun 2025 | +16.3% |
| Mar 2025 | +24.3% |
| Dec 2024 | +33.7% |
| Sep 2024 | +8.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets HKHC
| FY Dec 2025 | +0.3% |
| FY Dec 2024 | +5.9% |
| FY Dec 2023 | -0.8% |
| FY Dec 2022 | -56.0% |
| FY Dec 2021 | -40.8% |
| Jun 2026 | +2.3% |
| Mar 2026 | +2.5% |
| Dec 2025 | +0.3% |
| Sep 2025 | +5.0% |
| Jun 2025 | +4.8% |
| Mar 2025 | +7.2% |
| Dec 2024 | +5.9% |
| Sep 2024 | +2.3% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate -17%, not meaningful
Return on invested capital HKHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+0.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed HKHC
| FY Dec 2025 | +0.6% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | +0.2% |
| Mar 2026 | +0.2% |
| Dec 2025 | +0.6% |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
7.73x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing HKHC
| FY Dec 2025 | 83.93x |
| FY Dec 2024 | 7.02x |
| FY Dec 2023 | 241.56x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 13.15x |
| Mar 2026 | 11.22x |
| Dec 2025 | 83.93x |
| Sep 2025 | 7.24x |
| Jun 2025 | 15.64x |
| Mar 2025 | 8.28x |
| Dec 2024 | 7.02x |
| Sep 2024 | 21.04x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$330.8M
market value at close 2026-10-27 on 2026-08-11 shares, plus LongTermDebt as filed 2022-12-31 (42 months older than the period end) (includes the current portion), minus cash 2026-06-30
Enterprise value HKHC
| FY Dec 2025 | $404.6M |
| FY Dec 2024 | $659.9M |
| FY Dec 2023 | $4.8B |
| FY Dec 2022 | $1.1B |
| FY Dec 2021 | $8.1B |
| Jun 2026 | $584.2M |
| Mar 2026 | $581.7M |
| Dec 2025 | $404.6M |
| Sep 2025 | $668.5M |
| Jun 2025 | $766.0M |
| Mar 2025 | $600.0M |
| Dec 2024 | $659.9M |
| Sep 2024 | $289.3M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield HKHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | -0.2% |
| FY Dec 2021 | -0.0% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -9%, PEG needs growth
PEG, trailing HKHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.03x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | 0.02x |
| Jun 2025 | n/a |
| Mar 2025 | 1.01x |
| Dec 2024 | 0.03x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $72.8M | $57.2M | $47.3M | $16.6M |
| Gross profit | n/a | n/a | $1.4M | $1.4M |
| Operating income | $11.1M | -$15.1M | -$1.8M | -$9.9M |
| Net income | $5.1M | $92.5M | -$4.5M | -$8.9M |
| EPS (diluted) | 0.27 | 5.07 | -0.25 | -0.70 |
| Operating cash flow | -$43.1M | $11.8M | $25.5M | -$1.8M |
| Cash | $36.9M | $14.4M | $10.5M | $49.0K |
| Long-term debt | n/a | n/a | n/a | $3.5M |
| Dividends paid | $6.3M | $988.0K | n/a | n/a |
SEC XBRL, fiscal years, as known on 2026-10-28
HKHC Stock Sonar score 5/7 axes
Find similar shapesCompareHKHC ranks highest on risk and compliance (96th percentile) and insider conviction (90th), and lowest on financial health (46th), among Financial Services peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HKHC filings, in plain words
Are Horizon Kinetics insiders buying or selling HKHC?
In the 180 days to 2026-10-28, Horizon Kinetics insiders were net buyers, a net $127.5K across purchases and sales reported on Form 4, by 5 buyers.
Read the full summary
In the 180 days to 2026-10-28, Horizon Kinetics insiders were net buyers of HKHC, a net $127.5K across purchases and sales reported on Form 4 by 5 buyers. 5 different insiders reported purchases within the last 90 days, a cluster buy, which is rarer than a single purchase. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
